Gene · 1645
Papers1,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of candidate biomarkers associated with gastric cancer prognosis based on an integrated bioinformatics analysis. | J Gastrointest Oncol | 2022 | 36092336 | PubTator, text mining | PubMed |
| Genomic Landscape Alterations in Primary Tumor and Matched Lymph Node Metastasis in Hormone-Naïve Prostate Cancer Patients. | Cancers (Basel) | 2022 | 36077746 | PubTator, text mining | PubMed |
| Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance. | Int J Mol Sci | 2022 | 36076996 | PubTator, text mining | PubMed |
| AKR1C1 Protects Corneal Epithelial Cells Against Oxidative Stress-Mediated Ferroptosis in Dry Eye. | Invest Ophthalmol Vis Sci | 2022 | 36066316 | PubTator, text mining | PubMed |
| Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer. | Oxid Med Cell Longev | 2022 | 36062197 | PubTator, text mining | PubMed |
| Cortisol Stimulates Local Progesterone Withdrawal Through Induction of AKR1C1 in Human Amnion Fibroblasts at Parturition. | Endocrinology | 2022 | 36048433 | PubTator, text mining | PubMed |
| Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas. | Front Immunol | 2022 | 36045691 | PubTator, text mining | PubMed |
| Nitroreduction: A Critical Metabolic Pathway for Drugs, Environmental Pollutants, and Explosives. | Chem Res Toxicol | 2022 | 36044734 | PubTator, text mining | PubMed |
| Brusatol sensitizes endometrial hyperplasia and cancer to progestin by suppressing NRF2-TET1-AKR1C1-mediated progestin metabolism. | Lab Invest | 2022 | 36038734 | PubTator, text mining | PubMed |
| Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line. | Front Pharmacol | 2022 | 36034868 | PubTator, text mining | PubMed |
| Targeting of the intracellular redox balance by metal complexes towards anticancer therapy. | Front Chem | 2022 | 36034648 | PubTator, text mining | PubMed |
| A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer. | Front Endocrinol (Lausanne) | 2022 | 36034466 | PubTator, text mining | PubMed |
| YT521-B homology domain family proteins as N6-methyladenosine readers in tumors. | Front Genet | 2022 | 36017491 | PubTator, text mining | PubMed |
| Markers of Oxidative Stress in Obstetrics and Gynaecology-A Systematic Literature Review. | Antioxidants (Basel) | 2022 | 36009196 | PubTator, text mining | PubMed |
| Potential ferroptosis key genes in calcific aortic valve disease. | Front Cardiovasc Med | 2022 | 36003913 | PubTator, text mining | PubMed |
| PredictiveNetwork: predictive gene network estimation with application to gastric cancer drug response-predictive network analysis. | BMC Bioinformatics | 2022 | 35974335 | PubTator, text mining | PubMed |
| Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing. | Front Immunol | 2022 | 35967424 | PubTator, text mining | PubMed |
| Identification of novel prognostic risk signature of breast cancer based on ferroptosis-related genes. | Sci Rep | 2022 | 35962042 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma. | Biomed Res Int | 2022 | 35937391 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1645/papers?page=19